Targeting tumour-intrinsic N <sup>7</sup> -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacyHai‐Ning Liu, Shuibin Lin, Sui Peng et al.|Gut|2022Cited by 79
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular CarcinomaSui Peng, Ming Kuang, Shuling Chen et al.|Cancer Immunology Research|2022Cited by 72
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrencesShuling Chen, Ming Kuang, Cheng Huang et al.|Gut|2023Cited by 66
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYing–Hong Shi, Enxiao Li, Guohong Han et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 39
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytesZimin Song, Shunli Shen|Hepatology International|2023Cited by 20